Westfuller Advisors’s Ginkgo Bioworks DNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-1,698
Closed -$14.1K 763
2025
Q4
$14.1K Buy
+1,698
New +$18.3K 0.01% 418

Other funds holding DNA

Westfuller Advisors's DNA Position: Q1 2026 in Review

Westfuller Advisors sold out of Ginkgo Bioworks (DNA) in Q1 2026, closing a stake of 1,698 shares — an estimated $14.1K sold.

Westfuller Advisors first reported a position in DNA in Q4 2025 and held it in 1 quarter. The position peaked at $14.1K in Q4 2025. 174 funds tracked by Wall St. Rank hold DNA as of Q1 2026.

  • Westfuller Advisors reported no remaining Ginkgo Bioworks position as of Q1 2026 after selling out during the quarter.
  • Westfuller Advisors sold 1,698 Ginkgo Bioworks shares in Q1 2026, an estimated $14.1K.
  • Westfuller Advisors first reported a position in Ginkgo Bioworks in Q4 2025 and held it in 1 quarter.
  • Westfuller Advisors's Ginkgo Bioworks position peaked at $14.1K in Q4 2025.
  • 174 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q1 2026.

Based on Westfuller Advisors's 13F filing for Q1 2026, filed 28 Apr 2026.